![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/remedy-pharmaceuticals-gets-rights-to-acute-stroke-drug-back-from-biogen-announces-clinically-meaningful-and-statistically-significant-results-from-pre-specified-subgroup-and-post-hoc-analyses-of-phase-3-study-302157095.html
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sugarmds-llc-issues-voluntary-nationwide-recall-advanced-glucose-support-supplements-capsules-due
https://www.raps.org/news-and-articles/news-articles/2019/5/generic-drugmaker-admits-to-price-fixing
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203379
https://www.pharmacompass.com/pdf/news/ammtek-amglidia-glibenclamide-receives-approval-in-europe-1528520473.pdf
https://www.europeanpharmaceuticalreview.com/news/73085/amglidia-neonatal-diabetes/
https://www.raps.org/news-and-articles/news-articles/2018/2/ema%E2%80%99s-chmp-recommends-five-new-medicines-for-appro?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails&_zs=VHOsL1&_zl=k7BK4
http://www.pharmatimes.com/news/five_new_medicines_backed_for_eu_approval_1223972
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/02/news_detail_002907.jsp&mid=WC0b01ac058004d5c1
http://www.pharmatimes.com/news/biogen_reveals_tysabri_failure_in_stroke_trial_1221184
https://www.statnews.com/2016/12/22/pharma-generic-price-fixing/
http://www.financialexpress.com/industry/sun-pharma-most-at-risk-in-us-probe/481239/
http://www.financialexpress.com/india-news/price-fixing-lawsuit-slapped-against-aurobindo-pharma-mylan-pharmaceuticals-others-in-us/476960/
http://www.forbes.com/sites/nathanvardi/2016/12/14/the-man-the-feds-are-using-to-first-crack-open-their-big-antitrust-case-against-generic-drug-makers/#2507fffd6124
http://www.pharma-excipients.ch/2016/11/16/evaluation-of-glibenclamide-microspheres-for-sustained-release/
https://www.pharmacompass.com/pdf/news/zydus-pharms-usa-incs-generic-glyburide-approved-in-us-as-an-antidiabetic-drug-1463220186.pdf
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-nod-to-sell-generic-diabetes-drug/articleshow/52220100.cms
http://www.pharma-excipients.ch/2016/03/03/comparative-evaluation-of-porous-silica-based-carriers-for-lipids-and-liquid-drug-formulations/
http://www.business-standard.com/article/pti-stories/zydus-cadila-gets-usfda-nod-for-anti-diabetics-tablets-116030100389_1.html